Cardiome reports fourth quarter and full year 2014 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Cardiome Pharma (CRME) Misses Q4 EPS by 25c
March 12, 2015 7:04 AM EDTCardiome Pharma (NASDAQ: CRME) reported Q4 EPS of ($0.39), $0.25 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $7 million versus the consensus estimate of $8.54 million.
For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.
... More